Literature DB >> 16929376

Long-term risks for thyroid cancer and other neoplasms after exposure to radiation.

Arthur B Schneider1, David H Sarne.   

Abstract

Radiation-related thyroid cancer continues to be a clinical concern for two reasons: the risks associated with the widespread use of radiation treatments for benign conditions in the middle of the last century persist for decades after exposure; and radiation continues to be an effective component of the treatment of several childhood malignancies. Patients who were irradiated in the head and neck area need to be evaluated for thyroid cancer, benign thyroid nodules, hyperparathyroidism, salivary-gland neoplasms and neural tumors, including acoustic neuromas. Radiation-related thyroid cancers appear to have the same clinical behavior as other thyroid cancers, but many irradiated patients are entering the age range when more aggressive neoplasms occur. In this paper, we review how to approach the clinical management of a patient with a history of radiation exposure in the thyroid area, and how to treat radiation-exposed patients who develop related neoplasms, especially thyroid cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16929376     DOI: 10.1038/ncpendmet0022

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  33 in total

1.  Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism.

Authors:  Amit Mahajan; Lee F Starker; Monica Ghita; Robert Udelsman; James A Brink; Tobias Carling
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 2.  Exposing the thyroid to radiation: a review of its current extent, risks, and implications.

Authors:  Bridget Sinnott; Elaine Ron; Arthur B Schneider
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

Review 3.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

4.  Second cancer after total-body irradiation (TBI) in childhood.

Authors:  Pascal Pommier; Marie Pierre Sunyach; Caroline Pasteuris; Didier Frappaz; Christian Carrie
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

5.  Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort.

Authors:  Michael Jacob Adams; Roy E Shore; Ann Dozier; Steven E Lipshultz; Ronald G Schwartz; Louis S Constine; Thomas A Pearson; Marilyn Stovall; Kelly Thevenet-Morrison; Susan G Fisher
Journal:  Radiat Res       Date:  2010-10-26       Impact factor: 2.841

6.  Patients exposed to diagnostic head and neck radiation for the management of shunted hydrocephalus have a significant risk of developing thyroid nodules.

Authors:  Jennifer H Aldrink; Brent Adler; Jesse Haines; Daniel Watkins; Mika Matthews; Lacey Lubeley; Wei Wang; Denis R King
Journal:  Pediatr Surg Int       Date:  2016-04-15       Impact factor: 1.827

7.  Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.

Authors:  Faina Linkov; Robert L Ferris; Zoya Yurkovetsky; Adele Marrangoni; Lyudmila Velikokhatnaya; William Gooding; Brian Nolan; Matthew Winans; Eric R Siegel; Anna Lokshin; Brendan C Stack
Journal:  Proteomics Clin Appl       Date:  2008-10-10       Impact factor: 3.494

8.  Size, number, and distribution of thyroid nodules and the risk of malignancy in radiation-exposed patients who underwent surgery.

Authors:  Dan V Mihailescu; Arthur B Schneider
Journal:  J Clin Endocrinol Metab       Date:  2008-04-01       Impact factor: 5.958

9.  Cancer incidence in the Middle Eastern population of California, 1988-2004.

Authors:  Kiumarss Nasseri; Paul K Mills; Mark Allan
Journal:  Asian Pac J Cancer Prev       Date:  2007 Jul-Sep

10.  A prospective study of medical diagnostic radiography and risk of thyroid cancer.

Authors:  Gila Neta; Preetha Rajaraman; Amy Berrington de Gonzalez; Michele M Doody; Bruce H Alexander; Dale Preston; Steven L Simon; Dunstana Melo; Jeremy Miller; D Michal Freedman; Martha S Linet; Alice J Sigurdson
Journal:  Am J Epidemiol       Date:  2013-03-25       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.